RECORD #541118


012862677 | AH | 63040804 | | 2125884 | 5/25/2005 12:00:00 AM | djd L knee , htn , bee sting allergy , obesity , hepatitis C virus | | DIS | Admission Date: 7/16/2005 Report Status:

Discharge Date: 9/22/2005
****** FINAL DISCHARGE ORDERS ******
CUSSON , DOUGLASS 854-17-37-0
Cuse
Service: ORT
DISCHARGE PATIENT ON: 2/17/05 AT 01:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: WILDE , ULYSSES , M.D.
DISPOSITION: Rehabilitation
DISCHARGE MEDICATIONS:
TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H
PRN Other:fever greater than 101
Instructions: Do not exceed 4000mg in 24 hours.
ATENOLOL 100 MG PO QD
CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO QD
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
FAMOTIDINE 20 MG PO BID
Override Notice: Override added on 9/4/05 by
POWSKEY , JOHNIE T.
on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref #
71100755 )
POTENTIALLY SERIOUS INTERACTION: FAMOTIDINE &amp; BUPIVACAINE
HCL Reason for override: monitor INR
Previous override information:
Override added on 8/6/05 by SUCHLA , DON STEVE , M.D.
on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref #
66247212 )
POTENTIALLY SERIOUS INTERACTION: FAMOTIDINE &amp; BUPIVACAINE
HCL Reason for override: monitor INR
FERROUS SULFATE 325 MG PO TID
Food/Drug Interaction Instruction Avoid milk and antacid
FOLATE ( FOLIC ACID ) 1 MG PO QD
MVI ( MULTIVITAMINS ) 1 TAB PO QD
OXYCODONE 10-20 MG PO Q3H PRN Pain
METAMUCIL SUGAR FREE ( PSYLLIUM ( METAMUCIL ) SU... )
1 PACKET PO QD PRN Constipation
Instructions: may be given with the patients choice of
beverage
COUMADIN ( WARFARIN SODIUM ) 7.5 MG PO QPM
Starting ROUTINE , 20:00 ( Standard Admin Time )
Instructions: Dose for 10/1/05 .  Please check INR daily
while in rehab and
then QMonday/Thursday. Goal INR=1.5-2.5 , duration is 3
weeks. INR at discharge was 1.1 after 6mg. Have results
sent to JMC primary care provider.
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Reason: Override added on 9/4/05 by MAFFUCCI , NEWTON L.
on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref #
71100755 ) SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL
SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL
Reason for override: monitor INR
Previous override information:
Override added on 8/6/05 by WINNE , JOHNNIE TYRON , M.D.
on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref #
66247212 ) SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL
SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL
Reason for override: monitor INR
OXYCONTIN ( OXYCODONE CONTROLLED RELEASE ) 10 MG PO Q12H
CHOLECALCIFEROL 400 UNITS PO QD
DIET: No Restrictions
ACTIVITY: Full weight-bearing: please increase ROM , leg strength , and work on ambulation
FOLLOW UP APPOINTMENT( S ):
Please follow-up with Dr. Riis in 4-5 weeks ,
primary care physician ,
Arrange INR to be drawn on 1/3/05 with f/u INR's to be drawn every
1daywhileinrehab , thenqMOnday/Thursday days. INR's will be followed by Burl Mulholland , MD at ( 942 ) 570-8424 AH primary care provider
ALLERGY: NKA
ADMIT DIAGNOSIS:
djd L knee , htn , bee sting allergy , obesity , hepatitis C virus
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
djd L knee , htn , bee sting allergy , obesity , hepatitis C virus
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
same
OPERATIONS AND PROCEDURES:
11/3/05 BONFIELD , ALTON , M.D.
L. TOTAL KNEE REPALACEMENT
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
none
BRIEF RESUME OF HOSPITAL COURSE:
54 year-old female patient with PMH htn , obesity , bee sting allergy ,
and hepatitis C , underwent left total
knee arthroplasty on 11/4/05 .  The patient tolerated the procedure well was
managed per the pathway and had no major events.
Neurologic: Pain was initially managed with an epidural followed by oral
pain mediciation.
Respiratory: The patient's oxygen saturations gradually improved and at
the time of discharge they were weaned to room air.
Cardiovascular: The patient was maintained on his/her home blood
pressure medications and their blood pressure remained well controlled
throughtout their hospitalization.
Hematologic: The patient's hematocrit remained stable throughout the
hospitalization and was 31.4 on POD#2. INR increased
slowly with coumadin and at discharge was xx.
Fluids/Electrolytes/Nutrition: Their potassium and magnesium were
checked frequently during the admission and repleted as needed. They
were tolerating a regular diet at discharge.
Orthopedic: The patient worked with physical therapy and had a achieved
good ROM and was able to ambulate with assist at discharge. Their wound
appeared clean , dry , and intact.
ADDITIONAL COMMENTS: Dry sterile dressing to wound. May leave open to air when dry. May
shower when wound dry x48 hrs. Staple removal/steri-strip application ( on
POD 14 , January , 2005 ). Coumadin x 3 wks. Day after discharge and
biweekly PT/INR blood draws ( q M/R ). Follow up with doctor as scheduled
DISCHARGE CONDITION: Stable
TO DO/PLAN:
1 ) Please arrange for blood draws ( PT/INR ) on day after discharge and Q
M/R thereafter. Pleae check daily while in rehab. Have reports phoned in
to Getken Hospital PCP , Dudley Brunecz , MD at ( 727 ) 530-3492. 2 ) Follow up
with doctor as scheduled. Continue
working on knee ROM , strengthening , and ambulation.
3 ) Please check Magnesium level 1/3/05 AM and phone results to PCP for
further instructions; pt with hx of hypomagnesemia , Mg=1.7 during
hospitalization and s/p repletion with 2000mg Magnesium Gluconate PO x 1
on 10/1/05 . 
No dictated summary
ENTERED BY: STENGEL , MARCELINO N , M.D. ( XV344 ) 2/17/05 @ 11:00 AM
****** END OF DISCHARGE ORDERS ******
[report_end]
